Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol CHP2 contributors: mct - updated : 11-05-2011
HGNC name calcineurin B homologous protein 2
HGNC id
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • C-terminal region of CHP2 contains a nuclear export sequence (NES), that, with calcium, control the subcellular distribution of CHP2 (
  • N-myristolated and include EF-hand motifs that bind Ca2+ (
  • HOMOLOGY
    Homologene
    FAMILY calcineurin B homologous protein family
    CATEGORY
    SUBCELLULAR LOCALIZATION     intracellular
    intracellular,cytoplasm
    basic FUNCTION
  • serves as an obligatory subunit that is required both for supporting the basic activity and regulating the pH-sensing of SLC9A1 via interactions between distinct parts of these proteins )
  • required for histone H3 lysine 14 (H3K14) deacetylation, and mediates transcriptional repression by limiting RNA polymerase II access to heterochromatin
  • involved in transcriptional silencing at heterochromatic regions (
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule
    protein
  • associates with the histone histone deacetylase complex, is required for histone H3 lysine 14 (H3K14) deacetylation, and mediates transcriptional repression by limiting RNA polymerase II access to heterochromatin
  • interaction between CHP2 and SLC9A 1 (NHE1), two membrane proteins, is essential for protecting cells from serum deprivation-induced death
  • cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --over  
    affects the biological behavior of ovarian cancer cell line OVCAR3 and is one of key mechanisms for ovarian carcinoma progression (
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
    Therapy target
    SystemTypeDisorderPubmed
    cancer  
    may be an attractive target for biological anticancer therapy
    ANIMAL & CELL MODELS